Coda Octopus Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Coda Octopus Group, Inc. on May 29, 2024, covering events occurring on May 23, 2024. The Company is a Delaware corporation with its principal executive offices in Orlando, Florida, and its common stock trades on the Nasdaq under the symbol "CODA."
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on corporate governance changes.
Material Changes
The primary material change reported is the election of a new director to the Board of Directors.
- New Director: Dr. Angus McFadzean was elected as a director, effective July 1, 2024.
- Background: Dr. McFadzean is a co-founder of the Company's Marine Technology Business and has been affiliated with the Company since 1994. Since 2013, he has served as the Research and Development Director for the Marine Technology subsidiary, overseeing R&D programs for the Echoscope and DAVD, as well as the Cyber Security Management Program.
- Education: He holds a master's degree in electrical and electronic engineering and a PhD from Heriot-Watt University.
Compensation and Equity Grants
In connection with his election, Dr. McFadzean received the following compensation:
- Stock Grant: 6,107 shares of the Company's common stock, vesting on the first anniversary of his election.
- Director Fees: He will be compensated for board services in accordance with the Company's regular director compensation practices.
Outlook, Risks, and Contingencies
The filing does not provide updated guidance, outlook, management commentary on future operations, or new risk factors. No unusual items or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Verify the effective date of Dr. McFadzean's board service (July 1, 2024).
- Confirm the vesting schedule for the 6,107 shares granted to the new director.
- Review the Company's regular director compensation practices to understand the cash fee component of the new director's remuneration.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.